Related Experiment Video
Updated: Aug 19, 2026

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
Megakaryocyte induced fibroblast proliferation is enhanced by costimulation with IL-6/IL-3 and dependent on secretory
B Schmitz1, C Wickenhauser, J Thiele
1Institute of Pathology, University of Cologne, Germany.
Abstract:
Experimental data are in keeping with the finding that megakaryocytes isolated from normal human bone marrow may promote fibroblast growth. This effect can be significantly enhanced by interleukin (IL)-3. In this context it has been demonstrated that IL-3 induces the release of platelet-derived growth factor (PDGF) and transforming growth factor beta1 (TGFbeta1) from megakaryocytes, factors known to enhance fibroblast proliferation. The present in vitro study was performed to elucidate the action of several other cytokines which are able to influence the different steps of megakaryocyte maturation and function like stem cell factor (SCF), IL-6, and leukemia inhibitory factor (LIF) as well. Following an appropriate experimental design we were able to show that none of the mentioned cytokines enhanced megakaryocyte dependent fibroblast proliferation in the coculture assays. On the other hand, IL-6 in combination with IL-3 surpassed the IL-3 dependent action significantly. However, the combined IL-3/IL-6 effect was not explainable by an increased PDGF/TGF-beta secretion of the megakaryocytes. In transwell experiments the inhibition of cell-to-cell contact via tissue culture inserts generated a conspicuous impairment of fibroblast growth in the IL-3/IL-6 treated cocultures. This reversal surpassed even the effect on the untreated and IL-3 stimulated cocultures. Hence, a direct contact of both cell types probably inducing adhesion phenomenons and warranting a certain threshold of local PDGF/TGF-beta concentration is a prerequisite for the proliferative effect on fibroblasts in the costimulation experiments. These results are of special interest regarding the evolution of myelofibrosis in chronic myeloproliferative disorders (CMPDs) because (1) various progenitor cells including the megakaryocytic lineage are hypersensitive towards IL-3 and (2) an abnormal secretion of IL-6 is described for megakaryocytes in these disorders.
Insights
Megakaryocytes promote fibroblast growth, enhanced by interleukin-3 (IL-3). IL-6 combined with IL-3 boosts this effect, requiring direct cell contact for fibroblast proliferation, relevant to myelofibrosis.
Area of Science:
- Hematology
- Cell Biology
- Oncology
Background:
- Megakaryocytes from human bone marrow can promote fibroblast growth.
- Interleukin-3 (IL-3) significantly enhances this megakaryocyte-driven fibroblast proliferation.
- IL-3 stimulates megakaryocytes to release platelet-derived growth factor (PDGF) and transforming growth factor beta1 (TGF-beta1), key factors for fibroblast growth.
Purpose of the Study:
- To investigate the in vitro effects of stem cell factor (SCF), IL-6, and leukemia inhibitory factor (LIF) on megakaryocyte-dependent fibroblast proliferation.
- To elucidate the mechanisms underlying the synergistic effects of IL-3 and IL-6 on fibroblast growth.
- To explore the role of cell-to-cell contact in megakaryocyte-fibroblast interactions.
Main Methods:
- Coculture assays involving human bone marrow-derived megakaryocytes and fibroblasts.
- Treatment with various cytokines including IL-3, IL-6, SCF, and LIF.
- Transwell experiments to assess the impact of cell-to-cell contact inhibition.
- Measurement of PDGF and TGF-beta1 secretion.
Main Results:
- SCF, IL-6, and LIF alone did not enhance megakaryocyte-dependent fibroblast proliferation.
- The combination of IL-6 and IL-3 significantly enhanced fibroblast proliferation beyond IL-3 alone.
- This enhanced proliferation was not due to increased PDGF/TGF-beta1 secretion.
- Inhibition of cell-to-cell contact using transwell inserts markedly impaired fibroblast growth in IL-3/IL-6 treated cocultures.
Conclusions:
- Direct cell-to-cell contact between megakaryocytes and fibroblasts is crucial for the proliferative effect, likely by maintaining local growth factor concentrations.
- The synergistic effect of IL-3 and IL-6 on fibroblast proliferation is dependent on cell adhesion phenomena.
- These findings are significant for understanding myelofibrosis development in chronic myeloproliferative disorders, given megakaryocyte hypersensitivity to IL-3 and abnormal IL-6 secretion.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
Introduction to Fibroblasts
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Overview of Cell-Matrix Interactions
Intracellular Signaling Affects Focal Adhesions
Some...

